Prot #42756493BLC2003: A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGF

Project: Research project

Project Details

StatusActive
Effective start/end date8/6/21 → 9/11/26

Funding

  • Janssen Research & Development, LLC ((OE) Prot #42756493BLC2003)